About A R Life Sciences
A R Life Sciences is a company based in Hyderabad (India) founded in 2004 by K Subba Reddy. It operates as a B2B. The company has 308 employees as of March 31, 2023. A R Life Sciences offers products and services including Pharmaceutical Intermediates, Active Pharmaceutical Ingredients, Dabigatran Intermediates, and Bendamustine Intermediates. A R Life Sciences operates in a competitive market with competitors including Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
- Headquarter Hyderabad, India
- Employees 308 as on 31 Mar, 2023
- Founders K Subba Reddy
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name A. R. Life Sciences Private Limited
- Date of Incorporation 23 Aug, 2007
- Jurisdiction Rangareddy, Telangana, India
-
Annual Revenue
$22.86 M (USD)-14.56as on Mar 31, 2023
-
Net Profit
$7.47 K (USD)-99.37as on Mar 31, 2023
-
EBITDA
$1.51 M (USD)-21.11as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
308
as on Mar 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of A R Life Sciences
A R Life Sciences offers a comprehensive portfolio of products and services, including Pharmaceutical Intermediates, Active Pharmaceutical Ingredients, Dabigatran Intermediates, and Bendamustine Intermediates.
Raw materials used in synthesizing pharmaceutical drugs
Key components for formulating medicines and treatments
Materials for blood-thinning drug production
Substances for chemotherapy drug manufacturing
People of A R Life Sciences
Unlock access to complete
Unlock access to complete
Funding Insights of A R Life Sciences
Detailed funding history for A R Life Sciences
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by A R Life Sciences
Investment portfolio details for A R Life Sciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - A R Life Sciences
Detailed financials for A R Life Sciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
A R Life Sciences Comparisons
Peer comparison for A R Life Sciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of A R Life Sciences
A R Life Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical and biotechnology company
|
|
| Locked | Locked | Locked |
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
|
|
| Locked | Locked | Locked |
APIs and drug products are developed and valorized in pharmaceuticals.
|
|
| Locked | Locked | Locked |
APIs, intermediates, and biochemical reagents are developed and manufactured.
|
|
| Locked | Locked | Locked |
APIs are developed and manufactured for therapeutic areas.
|
|
| Locked | Locked | Locked |
Contract development, manufacturing, and analytical services for APIs are offered.
|
Detailed competitors of A R Life Sciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on A R Life Sciences
Complete news archive for A R Life Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about A R Life Sciences
A R Life Sciences was founded in 2004.
A R Life Sciences is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
As of Mar 31, 2023, the latest employee count at A R Life Sciences is 308.
Annual revenue of A R Life Sciences is $22.86M as on Mar 31, 2023.
A. R. Life Sciences Pvt. Ltd., based in Hyderabad, India, produces and exports active pharmaceutical ingredients and intermediates. The company adheres to ISO 9001:2015 and GMP standards, with one FDA-approved unit, focusing on high-purity products for global markets. They support regulatory compliance through documentation and serve sectors like anti-coagulants and cancer treatments.
A R Life Sciences's top competitors include Laurus Labs, Symbiotec and Beijing Biostar Technologies.
A R Life Sciences offers Pharmaceutical Intermediates, Active Pharmaceutical Ingredients, Dabigatran Intermediates, and Bendamustine Intermediates.